COVID-19 and Kidney Disease
Researchers investigated COVID-19 diagnoses and related hospitalization or death in dialysis patients.
Since the onset of the pandemic, cardiovascular complications have been seen in patients with CKD and COVID-19.
A study examined the association of COVID-19 disease vs vaccination with kidney function and glomerular disease activity.
Patients hospitalized with COVID-19 face increased risk for long-term adverse outcomes such as major adverse kidney events.
There was no association between kidneys from active COVID-19-positive donors procured in 2023 and higher odds of nonuse.
The pooled proportion of all serious adverse effects related to remdesivir was 2.9%.
Results of an analysis to characterize the sequelae of COVID-19 infection among kidney transplant recipients.
Participants were analyzed for antibodies to the SARS-CoV-2 spike protein receptor-binding domain.
Patients receiving maintenance hemodialysis are at increased risk for post-COVID-19 complications and a high mortality rate.
Solid organ transplant recipients represent a population that is immunocompromised and at high risk of infection.
Of 3.7 million patients, 2% (n=76,000) had incident post-COVID-19 CKD.
There was an association between previous COVID-19 infection and higher antibody titers at 28 days.
Advertisement
Advertisement
